ECO Animal Health Group (LON:EAH) Stock Crosses Above 50-Day Moving Average – Should You Sell?

ECO Animal Health Group plc (LON:EAH) crossed above its fifty day moving average during trading on Tuesday . The stock has a fifty day moving average of GBX 69.65 ($0.87) and traded as high as GBX 71 ($0.89). ECO Animal Health Group shares last traded at GBX 67 ($0.84), with a volume of 432 shares.

Wall Street Analyst Weigh In

Separately, Shore Capital reiterated a “buy” rating on shares of ECO Animal Health Group in a research note on Friday, November 29th.

ECO Animal Health Group Stock Down 5.6 %

The company has a market cap of £45.39 million, a price-to-earnings ratio of 3,350.00 and a beta of -0.05. The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The firm has a 50-day moving average price of GBX 69.65 and a 200 day moving average price of GBX 94.45.

Insider Activity at ECO Animal Health Group

In other ECO Animal Health Group news, insider David Hallas purchased 15,500 shares of the stock in a transaction that occurred on Monday, December 2nd. The shares were acquired at an average cost of GBX 74 ($0.93) per share, with a total value of £11,470 ($14,353.65). 21.65% of the stock is currently owned by corporate insiders.

ECO Animal Health Group Company Profile

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.